Despite being the only study, which investigated miR-409-3p/Beclin 1 in OXA resistance, the findings suggest that this miRNA can enhance the chemosensitivity of colon cancer via Beclin 1 mediated autophagy inhibition [247]. Here, BECN1 is linked to malignant colon neoplasm.